Latest Insider Transactions at Kiniksa Pharmaceuticals, Ltd. (KNSA)
This section provides a real-time view of insider transactions for Kiniksa Pharmaceuticals, Ltd. (KNSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kiniksa Pharmaceuticals, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kiniksa Pharmaceuticals, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-6.41%
|
$2,690
$10.13 P/Share
|
|
Mar 16
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
775
+15.58%
|
-
|
|
Jan 15
2022
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
970
+0.89%
|
$8,730
$9.63 P/Share
|
|
Jan 15
2022
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,546
+20.79%
|
$13,914
$9.63 P/Share
|
|
Jan 15
2022
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
653
+16.02%
|
$5,877
$9.63 P/Share
|
|
Jul 15
2021
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
868
+0.81%
|
$9,548
$11.49 P/Share
|
|
Jul 15
2021
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
963
+18.14%
|
$10,593
$11.49 P/Share
|
|
Jul 15
2021
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
588
+17.51%
|
$6,468
$11.49 P/Share
|
|
Feb 10
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
1,137
-1.35%
|
$26,151
$23.07 P/Share
|
|
Feb 10
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
1,600
-100.0%
|
$36,800
$23.06 P/Share
|
|
Feb 10
2021
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+50.0%
|
$1,600
$1.59 P/Share
|
|
Feb 09
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
23,569
-21.81%
|
$542,087
$23.08 P/Share
|
|
Feb 09
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
20,401
-100.0%
|
$469,223
$23.04 P/Share
|
|
Feb 09
2021
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,401
+50.0%
|
$20,401
$1.59 P/Share
|
|
Feb 08
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
4,528
-4.02%
|
$104,144
$23.0 P/Share
|
|
Feb 08
2021
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
4,924
-100.0%
|
$113,252
$23.0 P/Share
|
|
Feb 08
2021
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,924
+50.0%
|
$4,924
$1.59 P/Share
|
|
Feb 03
2021
|
Thomas W. Beetham EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,477
-0.83%
|
$54,494
$22.09 P/Share
|
|
Feb 03
2021
|
Thomas W. Beetham EVP & Chief Legal Officer |
BUY
Conversion of derivative security
|
Direct |
300,000
+50.0%
|
-
|
|
Dec 31
2020
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
405
+15.65%
|
$6,075
$15.02 P/Share
|
|
Dec 31
2020
|
Qasim Rizvi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,161
-29.45%
|
$36,737
$17.67 P/Share
|
|
Dec 31
2020
|
Qasim Rizvi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,337
+50.0%
|
-
|
|
Dec 31
2020
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-29.45%
|
$22,049
$17.67 P/Share
|
|
Dec 31
2020
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,404
+50.0%
|
-
|
|
Oct 12
2020
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
99,330
-46.88%
|
$2,085,930
$21.02 P/Share
|
|
Oct 12
2020
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
150,700
-100.0%
|
$3,164,700
$21.02 P/Share
|
|
Oct 12
2020
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
150,700
+50.0%
|
$150,700
$1.59 P/Share
|
|
Oct 09
2020
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Indirect |
670
-0.32%
|
$14,070
$21.0 P/Share
|
|
Oct 09
2020
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Open market or private sale
|
Direct |
872
-100.0%
|
$18,312
$21.0 P/Share
|
|
Oct 09
2020
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
872
+50.0%
|
$872
$1.59 P/Share
|
|
Jun 30
2020
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
641
+26.5%
|
$5,769
$9.51 P/Share
|
|
Jun 06
2019
|
Baker Bros. Advisors LP |
BUY
Other acquisition or disposition
|
Direct |
29,680
+50.0%
|
-
|
|
Jun 06
2019
|
Baker Bros. Advisors LP |
SELL
Other acquisition or disposition
|
Indirect |
200,423
-66.94%
|
-
|
|
May 29
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
69,444
+7.16%
|
$1,249,992
$18.0 P/Share
|
|
May 29
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
830,999
+50.0%
|
-
|
|
May 29
2018
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
843,352
+26.44%
|
$16,023,688
$19.49 P/Share
|
|
May 29
2018
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
383,538
+50.0%
|
-
|
|
May 29
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
3,000,000
+50.0%
|
$54,000,000
$18.0 P/Share
|